Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2024-05
Stage
Series B
Founded
2010
Headcount
9
HQ
Newark, United States
Sector
Health Tech & Life Sciences
About
FEMSelect is a women-led medical technology company dedicated to advancing care for pelvic floor disorders. Its lead technology, EnPlace®, is a minimally invasive, mesh-free system for pelvic organ prolapse with strong safety and durability data. The company also offers Elitone® for non-surgical incontinence treatment. FEMSelect is committed to improving women's quality of life by providing innovative, patient-centered approaches to common conditions affecting women's health. The company was originally based in Israel and relocated its headquarters to the United States in May 2025.
Headcount over time
9 employees (2026-09) · 1 point
Offices
Newark, United States · HQ / main office
Q&A
- What is FEMSelect's primary focus?
- FEMSelect is a medical technology company focused on advancing care for pelvic floor disorders, particularly through its EnPlace® technology for pelvic organ prolapse treatment and Elitone® for non-surgical incontinence treatment.
- When did FEMSelect relocate its headquarters?
- FEMSelect relocated its headquarters from Israel to the United States in May 2025.
- Which investors participated in FEMSelect's October 2022 Series B funding round?
- In October 2022, FEMSelect raised $9,000,000 in Series B financing with participation from New Age Ventures and TriVentures.
- What is the employee count for FEMSelect?
- FEMSelect has 11-50 employees.
- What is the status of FEMSelect's EnPlace® technology?
- The EnPlace® system is FDA cleared and CE marked, and has been tested in a human trial in Israel. It is a minimally invasive, mesh-free system for pelvic organ prolapse.
- Who are the co-founders of FEMSelect?
- The co-founders of FEMSelect are Boaz Harari and Prof. Menahem Neuman.
- What is the total amount of funding FEMSelect has raised to date?
- FEMSelect has raised a total of $16,890,000 in funding.
Team · 9
Menachem Neuman
Founder · Founder & Medical Director
Boaz Harari
Founder · Founder & VP R&D
Sasha Schrode
CEO
Debbie Garner
President
Renee Selman
Executive Chairwoman of the Board
Rakesh Tailor
Board of Directors
Joel Chechik
CCO
Sherwyn Davidson
VP Quality Management and Regulatory
Karla Loken
Chief Medical Officer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicesgynecologyminimally-invasivemedical-technologieswomen-healthdoctorssurgeonshospitalstreatmentsfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | femselect.com |
|---|---|
| linkedin.com/company/28632694 | |
| facebook.com/FEMSelect | |
| YouTube | youtube.com/channel/UCUXuID-G3yt22gTkPV8Ovuw |
Identifiers & details
| Former names | ProAcccess, Pop Medical Solutions |
|---|---|
| Founded | 2010 |
| Employees (exact) | 9 |
| Offices | Newark |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | femselect.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514809243 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-10-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — annual_report (3), violation (1), people (1) |
| Registered address | המעיין 2 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-04 | דו~ח שנתי-הקצאת מניות |
| 2026-06-04 | דו~ח שנתי-עדכון כתובת |
| 2026-06-04 | עדכון הפרה |
| 2026-06-04 | דו~ח שנתי-הפחתת הון מוקצה |
| 2026-06-02 | עדכון בעלי תפקידים |